# Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation

> **NCT05589441** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 100 (estimated)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** salbutamol
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT05589441
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-28
- **Primary completion:** 2023-10-10
- **Final completion:** 2024-01-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589441, "Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05589441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*